A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)
Trial details
- Registry ID
- NCT06172257
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Dexamethasone
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)NCT06172257 | Oculis | Phase 3 | Completed | 2026-04-02Actual |
| A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)NCT05066997 | Oculis | Phase 2, Phase 3 | Completed | 2026-04-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |